ID   CDKL5_HUMAN             Reviewed;        1030 AA.
AC   O76039; Q14198; Q5H985; Q8IYC7; Q9UJL6;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   05-OCT-2010, entry version 105.
DE   RecName: Full=Cyclin-dependent kinase-like 5;
DE            EC=2.7.11.22;
DE   AltName: Full=Serine/threonine-protein kinase 9;
GN   Name=CDKL5; Synonyms=STK9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=98389628; PubMed=9721213; DOI=10.1006/geno.1998.5391;
RA   Montini E., Andolfi G., Caruso A., Buchner G., Walpole S.M.,
RA   Mariani M., Consalez G.G., Trump D., Ballabio A., Franco B.;
RT   "Identification and characterization of a novel serine-threonine
RT   kinase gene from the Xp22 region.";
RL   Genomics 51:427-433(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], INVOLVEMENT IN EIEE2, CHROMOSOMAL
RP   TRANSLOCATION, AND VARIANT PRO-791.
RX   PubMed=12736870; DOI=10.1086/375538;
RA   Kalscheuer V.M., Tao J., Donnelly A., Hollway G., Schwinger E.,
RA   Kuebart S., Menzel C., Hoeltzenbein M., Tommerup N., Eyre H.,
RA   Harbord M., Haan E., Sutherland G.R., Ropers H.-H., Gecz J.;
RT   "Disruption of the serine/threonine kinase 9 gene causes severe X-
RT   linked infantile spasms and mental retardation.";
RL   Am. J. Hum. Genet. 72:1401-1411(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 339-789.
RX   MEDLINE=97017517; PubMed=8864140;
RA   Krause S.W., Rehli M., Kreutz M., Schwarzfischer L., Paulauskis J.D.,
RA   Andreesen J.D.;
RT   "Differential screening leads to novel genetic markers of monocyte to
RT   macrophage maturation.";
RL   J. Leukoc. Biol. 60:540-545(1996).
RN   [5]
RP   INVOLVEMENT IN EIEE2.
RX   PubMed=15492925; DOI=10.1086/426462;
RA   Weaving L.S., Christodoulou J., Williamson S.L., Friend K.L.,
RA   McKenzie O.L.D., Archer H., Evans J., Clarke A., Pelka G.J.,
RA   Tam P.P.L., Watson C., Lahooti H., Ellaway C.J., Bennetts B.,
RA   Leonard H., Gecz J.;
RT   "Mutations of CDKL5 cause a severe neurodevelopmental disorder with
RT   infantile spasms and mental retardation.";
RL   Am. J. Hum. Genet. 75:1079-1093(2004).
RN   [6]
RP   INTERACTION WITH MECP2, FUNCTION, AUTOPHOSPHORYLATION, AND INVOLVEMENT
RP   IN EIEE2.
RX   PubMed=15917271; DOI=10.1093/hmg/ddi198;
RA   Mari F., Azimonti S., Bertani I., Bolognese F., Colombo E.,
RA   Caselli R., Scala E., Longo I., Grosso S., Pescucci C., Ariani F.,
RA   Hayek G., Balestri P., Bergo A., Badaracco G., Zappella M.,
RA   Broccoli V., Renieri A., Kilstrup-Nielsen C., Landsberger N.;
RT   "CDKL5 belongs to the same molecular pathway of MeCP2 and it is
RT   responsible for the early-onset seizure variant of Rett syndrome.";
RL   Hum. Mol. Genet. 14:1935-1946(2005).
RN   [7]
RP   FUNCTION, AUTOPHOSPHORYLATION, SUBCELLULAR LOCATION, AND
RP   CHARACTERIZATION OF VARIANTS EIEE2 PHE-152 AND SER-175.
RX   PubMed=16935860; DOI=10.1074/jbc.M606325200;
RA   Bertani I., Rusconi L., Bolognese F., Forlani G., Conca B.,
RA   De Monte L., Badaracco G., Landsberger N., Kilstrup-Nielsen C.;
RT   "Functional consequences of mutations in CDKL5, an X-linked gene
RT   involved in infantile spasms and mental retardation.";
RL   J. Biol. Chem. 281:32048-32056(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-171; SER-306; SER-407;
RP   SER-646; SER-720; SER-726 AND SER-761, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-171; SER-306; SER-375;
RP   SER-377; SER-407; SER-476; SER-488; SER-529; SER-681; SER-720 AND
RP   SER-726, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   VARIANTS EIEE2 PHE-152 AND SER-175, AND VARIANT PRO-791.
RX   PubMed=15499549; DOI=10.1086/426460;
RA   Tao J., Van Esch H., Hagedorn-Greiwe M., Hoffmann K., Moser B.,
RA   Raynaud M., Sperner J., Fryns J.-P., Schwinger E., Gecz J.,
RA   Ropers H.-H., Kalscheuer V.M.;
RT   "Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9)
RT   gene are associated with severe neurodevelopmental retardation.";
RL   Am. J. Hum. Genet. 75:1149-1154(2004).
RN   [12]
RP   INVOLVEMENT IN EIEE2.
RX   PubMed=15689447; DOI=10.1136/jmg.2004.026237;
RA   Scala E., Ariani F., Mari F., Caselli R., Pescucci C., Longo I.,
RA   Meloni I., Giachino D., Bruttini M., Hayek G., Zappella M.,
RA   Renieri A.;
RT   "CDKL5/STK9 is mutated in Rett syndrome variant with infantile
RT   spasms.";
RL   J. Med. Genet. 42:103-107(2005).
RN   [13]
RP   VARIANT EIEE2 ASN-72, AND VARIANT CYS-444.
RX   PubMed=16015284; DOI=10.1038/sj.ejhg.5201451;
RA   Evans J.C., Archer H.L., Colley J.P., Ravn K., Nielsen J.B., Kerr A.,
RA   Williams E., Christodoulou J., Gecz J., Jardine P.E., Wright M.J.,
RA   Pilz D.T., Lazarou L., Cooper D.N., Sampson J.R., Butler R.,
RA   Whatley S.D., Clarke A.J.;
RT   "Early onset seizures and Rett-like features associated with mutations
RT   in CDKL5.";
RL   Eur. J. Hum. Genet. 13:1113-1120(2005).
RN   [14]
RP   VARIANTS EIEE2 LEU-180 AND ALA-793.
RX   PubMed=16611748; DOI=10.1136/jmg.2006.041467;
RA   Archer H.L., Evans J., Edwards S., Colley J., Newbury-Ecob R.,
RA   O'Callaghan F., Huyton M., O'Regan M., Tolmie J., Sampson J.,
RA   Clarke A., Osborne J.;
RT   "CDKL5 mutations cause infantile spasms, early onset seizures, and
RT   severe mental retardation in female patients.";
RL   J. Med. Genet. 43:729-734(2006).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-368.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-374; GLN-574; ALA-734; PRO-791 AND
RP   GLY-1023.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [17]
RP   VARIANTS EIEE2 VAL-40; PRO-220 AND MET-718.
RX   PubMed=18790821; DOI=10.1093/brain/awn197;
RA   Bahi-Buisson N., Nectoux J., Rosas-Vargas H., Milh M., Boddaert N.,
RA   Girard B., Cances C., Ville D., Afenjar A., Rio M., Heron D.,
RA   N'guyen Morel M.A., Arzimanoglou A., Philippe C., Jonveaux P.,
RA   Chelly J., Bienvenu T.;
RT   "Key clinical features to identify girls with CDKL5 mutations.";
RL   Brain 131:2647-2661(2008).
RN   [18]
RP   VARIANTS EIEE2 VAL-40 AND PRO-220, AND CHARACTERIZATION OF VARIANTS
RP   EIEE2 VAL-40 AND PRO-220.
RX   PubMed=17993579; DOI=10.1136/jmg.2007.053504;
RA   Rosas-Vargas H., Bahi-Buisson N., Philippe C., Nectoux J., Girard B.,
RA   N'Guyen Morel M.A., Gitiaux C., Lazaro L., Odent S., Jonveaux P.,
RA   Chelly J., Bienvenu T.;
RT   "Impairment of CDKL5 nuclear localisation as a cause for severe
RT   infantile encephalopathy.";
RL   J. Med. Genet. 45:172-178(2008).
RN   [19]
RP   VARIANTS EIEE2 PRO-178; ILE-288 AND TYR-291.
RX   PubMed=18809835; DOI=10.1212/01.wnl.0000326592.37105.88;
RA   Elia M., Falco M., Ferri R., Spalletta A., Bottitta M., Calabrese G.,
RA   Carotenuto M., Musumeci S.A., Lo Giudice M., Fichera M.;
RT   "CDKL5 mutations in boys with severe encephalopathy and early-onset
RT   intractable epilepsy.";
RL   Neurology 71:997-999(2008).
RN   [20]
RP   VARIANT EIEE2 THR-399.
RX   PubMed=19253388; DOI=10.1002/ajmg.a.32711;
RA   Sprovieri T., Conforti F.L., Fiumara A., Mazzei R., Ungaro C.,
RA   Citrigno L., Muglia M., Arena A., Quattrone A.;
RT   "A novel mutation in the X-linked cyclin-dependent kinase-like 5
RT   (CDKL5) gene associated with a severe Rett phenotype.";
RL   Am. J. Med. Genet. A 149:722-725(2009).
RN   [21]
RP   VARIANTS EIEE2 THR-72 AND ARG-127, AND VARIANTS PRO-791 AND CYS-923.
RX   PubMed=19241098; DOI=10.1007/s10048-009-0177-1;
RA   Russo S., Marchi M., Cogliati F., Bonati M.T., Pintaudi M.,
RA   Veneselli E., Saletti V., Balestrini M., Ben-Zeev B., Larizza L.;
RT   "Novel mutations in the CDKL5 gene, predicted effects and associated
RT   phenotypes.";
RL   Neurogenetics 10:241-250(2009).
CC   -!- FUNCTION: Mediates phosphorylation of MECP2.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with MECP2.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=1; IntAct=EBI-1752465, EBI-375543;
CC       P06241:FYN; NbExp=1; IntAct=EBI-1752465, EBI-515315;
CC       P62993:GRB2; NbExp=1; IntAct=EBI-1752465, EBI-401755;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed in brain, lung, kidney, prostate,
CC       ovary, placenta, pancreas and testis.
CC   -!- PTM: Autophosphorylated.
CC   -!- DISEASE: Note=Chromosomal aberrations involving CDKL5 are found in
CC       patients manifesting early-onset seizures and spams and
CC       psychomotor impairment. Translocation t(X;6)(p22.3;q14);
CC       translocation t(X;7)(p22.3;p15).
CC   -!- DISEASE: Defects in CDKL5 are a cause of epileptic encephalopathy
CC       early infantile type 2 (EIEE2) [MIM:300672]; also known as
CC       atypical CDKL5-related Rett syndrome. EIEE2 is a severe form of
CC       epilepsy characterized by seizures or spasms beginning in infancy.
CC       Patients manifest features resembling Rett syndrome such as
CC       microcephaly, lack of speech development, stereotypic hand
CC       movements.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-10 is the initiator.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA61445.1; Type=Frameshift; Positions=415;
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/CDKL5";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y15057; CAA75342.1; -; mRNA.
DR   EMBL; AY217744; AAO64440.1; -; mRNA.
DR   EMBL; Z92542; CAI42485.1; -; Genomic_DNA.
DR   EMBL; AL109798; CAI42485.1; JOINED; Genomic_DNA.
DR   EMBL; AL109798; CAI41159.1; -; Genomic_DNA.
DR   EMBL; Z92542; CAI41159.1; JOINED; Genomic_DNA.
DR   EMBL; X89059; CAA61445.1; ALT_FRAME; mRNA.
DR   IPI; IPI00746301; -.
DR   PIR; S58296; S58296.
DR   RefSeq; NP_001032420.1; -.
DR   RefSeq; NP_003150.1; -.
DR   UniGene; Hs.659851; -.
DR   ProteinModelPortal; O76039; -.
DR   SMR; O76039; 14-300.
DR   IntAct; O76039; 3.
DR   MINT; MINT-7241055; -.
DR   STRING; O76039; -.
DR   PhosphoSite; O76039; -.
DR   PRIDE; O76039; -.
DR   Ensembl; ENST00000379989; ENSP00000369325; ENSG00000008086.
DR   Ensembl; ENST00000379996; ENSP00000369332; ENSG00000008086.
DR   GeneID; 6792; -.
DR   KEGG; hsa:6792; -.
DR   UCSC; uc004cym.1; human.
DR   CTD; 6792; -.
DR   GeneCards; GC0XP018443; -.
DR   H-InvDB; HIX0021511; -.
DR   HGNC; HGNC:11411; CDKL5.
DR   HPA; CAB011577; -.
DR   HPA; HPA002847; -.
DR   MIM; 300203; gene.
DR   MIM; 300672; phenotype.
DR   Orphanet; 3095; Atypical Rett syndrome.
DR   Orphanet; 3451; West syndrome.
DR   PharmGKB; PA36218; -.
DR   eggNOG; prNOG10368; -.
DR   HOGENOM; HBG443739; -.
DR   HOVERGEN; HBG050863; -.
DR   InParanoid; O76039; -.
DR   OMA; PVPRRVG; -.
DR   OrthoDB; EOG97DD1P; -.
DR   PhylomeDB; O76039; -.
DR   BRENDA; 2.7.11.22; 247.
DR   NextBio; 26529; -.
DR   ArrayExpress; O76039; -.
DR   Bgee; O76039; -.
DR   CleanEx; HS_CDKL5; -.
DR   Genevestigator; O76039; -.
DR   GermOnline; ENSG00000008086; Homo sapiens.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; IEA:EC.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IDA:HGNC.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Chromosomal rearrangement; Complete proteome;
KW   Disease mutation; Epilepsy; Kinase; Mental retardation;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1030       Cyclin-dependent kinase-like 5.
FT                                /FTId=PRO_0000085826.
FT   DOMAIN       13    297       Protein kinase.
FT   NP_BIND      19     27       ATP (By similarity).
FT   COMPBIAS    784    789       Poly-Lys.
FT   ACT_SITE    135    135       Proton acceptor (By similarity).
FT   BINDING      42     42       ATP (By similarity).
FT   MOD_RES     171    171       Phosphotyrosine.
FT   MOD_RES     306    306       Phosphoserine.
FT   MOD_RES     375    375       Phosphoserine.
FT   MOD_RES     377    377       Phosphoserine.
FT   MOD_RES     407    407       Phosphoserine.
FT   MOD_RES     476    476       Phosphoserine.
FT   MOD_RES     488    488       Phosphoserine.
FT   MOD_RES     529    529       Phosphoserine.
FT   MOD_RES     646    646       Phosphoserine.
FT   MOD_RES     681    681       Phosphoserine.
FT   MOD_RES     720    720       Phosphoserine.
FT   MOD_RES     726    726       Phosphoserine.
FT   MOD_RES     761    761       Phosphoserine.
FT   VARIANT      40     40       A -> V (in EIEE2; causes mislocalization
FT                                of the protein in the cytoplasm).
FT                                /FTId=VAR_058022.
FT   VARIANT      72     72       I -> N (in EIEE2).
FT                                /FTId=VAR_058023.
FT   VARIANT      72     72       I -> T (in EIEE2).
FT                                /FTId=VAR_058024.
FT   VARIANT     127    127       H -> R (in EIEE2).
FT                                /FTId=VAR_058025.
FT   VARIANT     152    152       C -> F (in EIEE2; affect activity; causes
FT                                mislocalization of the protein in the
FT                                cytoplasm).
FT                                /FTId=VAR_023560.
FT   VARIANT     175    175       R -> S (in EIEE2; affect activity; does
FT                                not affect the cellular distribution of
FT                                the protein).
FT                                /FTId=VAR_023561.
FT   VARIANT     178    178       R -> P (in EIEE2).
FT                                /FTId=VAR_058026.
FT   VARIANT     180    180       P -> L (in EIEE2).
FT                                /FTId=VAR_037635.
FT   VARIANT     220    220       L -> P (in EIEE2; causes mislocalization
FT                                of the protein in the cytoplasm).
FT                                /FTId=VAR_058027.
FT   VARIANT     288    288       T -> I (in EIEE2).
FT                                /FTId=VAR_058028.
FT   VARIANT     291    291       C -> Y (in EIEE2).
FT                                /FTId=VAR_058029.
FT   VARIANT     368    368       N -> H (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_036578.
FT   VARIANT     374    374       A -> T (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041997.
FT   VARIANT     399    399       N -> T (in EIEE2).
FT                                /FTId=VAR_058030.
FT   VARIANT     444    444       R -> C.
FT                                /FTId=VAR_058031.
FT   VARIANT     574    574       P -> Q (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041998.
FT   VARIANT     718    718       V -> M (in EIEE2).
FT                                /FTId=VAR_058032.
FT   VARIANT     734    734       T -> A (in dbSNP:rs55803460).
FT                                /FTId=VAR_041999.
FT   VARIANT     791    791       Q -> P (in dbSNP:rs35478150).
FT                                /FTId=VAR_023562.
FT   VARIANT     793    793       V -> A (in EIEE2; uncertain
FT                                pathogenicity).
FT                                /FTId=VAR_037636.
FT   VARIANT     923    923       R -> C.
FT                                /FTId=VAR_058033.
FT   VARIANT     999    999       V -> M (in dbSNP:rs35693326).
FT                                /FTId=VAR_037637.
FT   VARIANT    1023   1023       E -> G (in dbSNP:rs34166184).
FT                                /FTId=VAR_042000.
FT   CONFLICT    339    340       HR -> GT (in Ref. 4; CAA61445).
FT   CONFLICT    541    541       L -> W (in Ref. 4; CAA61445).
FT   CONFLICT    731    764       Missing (in Ref. 4; CAA61445).
SQ   SEQUENCE   1030 AA;  115538 MW;  8A1C9C438610EF08 CRC64;
     MKIPNIGNVM NKFEILGVVG EGAYGVVLKC RHKETHEIVA IKKFKDSEEN EEVKETTLRE
     LKMLRTLKQE NIVELKEAFR RRGKLYLVFE YVEKNMLELL EEMPNGVPPE KVKSYIYQLI
     KAIHWCHKND IVHRDIKPEN LLISHNDVLK LCDFGFARNL SEGNNANYTE YVATRWYRSP
     ELLLGAPYGK SVDMWSVGCI LGELSDGQPL FPGESEIDQL FTIQKVLGPL PSEQMKLFYS
     NPRFHGLRFP AVNHPQSLER RYLGILNSVL LDLMKNLLKL DPADRYLTEQ CLNHPTFQTQ
     RLLDRSPSRS AKRKPYHVES STLSNRNQAG KSTALQSHHR SNSKDIQNLS VGLPRADEGL
     PANESFLNGN LAGASLSPLH TKTYQASSQP GSTSKDLTNN NIPHLLSPKE AKSKTEFDFN
     IDPKPSEGPG TKYLKSNSRS QQNRHSFMES SQSKAGTLQP NEKQSRHSYI DTIPQSSRSP
     SYRTKAKSHG ALSDSKSVSN LSEARAQIAE PSTSRYFPSS CLDLNSPTSP TPTRHSDTRT
     LLSPSGRNNR NEGTLDSRRT TTRHSKTMEE LKLPEHMDSS HSHSLSAPHE SFSYGLGYTS
     PFSSQQRPHR HSMYVTRDKV RAKGLDGSLS IGQGMAARAN SLQLLSPQPG EQLPPEMTVA
     RSSVKETSRE GTSSFHTRQK SEGGVYHDPH SDDGTAPKEN RHLYNDPVPR RVGSFYRVPS
     PRPDNSFHEN NVSTRVSSLP SESSSGTNHS KRQPAFDPWK SPENISHSEQ LKEKEKQGFF
     RSMKKKKKKS QTVPNSDSPD LLTLQKSIHS ASTPSSRPKE WRPEKISDLQ TQSQPLKSLR
     KLLHLSSASN HPASSDPRFQ PLTAQQTKNS FSEIRIHPLS QASGGSSNIR QEPAPKGRPA
     LQLPDGGCDG RRQRHHSGPQ DRRFMLRTTE QQGEYFCCGD PKKPHTPCVP NRALHRPISS
     PAPYPVLQVR GTSMCPTLQV RGTDAFSCPT QQSGFSFFVR HVMREALIHR AQVNQAALLT
     YHENAALTGK
//
